← Back to headlines
Analysts Update Stock Ratings for Biotech and Technology Companies
Major financial institutions have issued new equity research ratings for several publicly traded firms, including Braze, Inhibrx Biosciences, Aktis Oncology, and Obsidian Therapeutics. The updates follow recent quarterly earnings reports and reflect analyst optimism regarding sector-specific growth trajectories.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
